Doyle, Derek: Notoriety to respectability: a short history of arsenic prior to its present day use in haematology. British Journal of Haematology, 2009, 145. vsk, nro 3, s. 309–317. doi:10.1111/j.1365-2141.2009.07623.x. (englanniksi)
Gibaud, Stéphane & Jaouen, Gérard: Arsenic - based drugs: from Fowler's solution to modern anticancer chemotherapy. Topics in Organometallic Chemistry, 2010, 32. vsk, s. 1–20. doi:10.1007/978-3-642-13185-1_1. Artikkelin verkkoversio. (englanniksi)
Zhu, J., Chen, Z., Lallemand-Breitenbach, V. & de Thé, H.: How acute promyelocytic leukaemia revived arsenic. Nature Reviews Cancer, 2002, 2. vsk, nro 9, s. 705–714. PubMed:12209159. doi:10.1038/nrc887. (englanniksi)
nih.gov
pubmed.ncbi.nlm.nih.gov
Jolliffe, D. M.: A history of the use of arsenicals in man. Journal of the Royal Society of Medicine, 1993, 86. vsk, nro 5, s. 287–289. PubMed:8505753. (englanniksi)
Zhu, J., Chen, Z., Lallemand-Breitenbach, V. & de Thé, H.: How acute promyelocytic leukaemia revived arsenic. Nature Reviews Cancer, 2002, 2. vsk, nro 9, s. 705–714. PubMed:12209159. doi:10.1038/nrc887. (englanniksi)
Gibaud, Stéphane & Jaouen, Gérard: Arsenic - based drugs: from Fowler's solution to modern anticancer chemotherapy. Topics in Organometallic Chemistry, 2010, 32. vsk, s. 1–20. doi:10.1007/978-3-642-13185-1_1. Artikkelin verkkoversio. (englanniksi)
